H&R GMBH & CO. KGAA (FRA:DE000A2E) H&R GmbH & Co. KGaA confirms earnings and sales trend through Q3-2018

Directive transparence : information réglementée

15/11/2018 08:03

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): 9-month figures/Quarterly / Interim Statement
H&R GmbH & Co. KGaA confirms earnings and sales trend through Q3-2018

15.11.2018 / 08:03
The issuer is solely responsible for the content of this announcement.

H&R GmbH & Co. KGaA confirms earnings and sales trend through Q3-2018

- Sales increase to EUR833.7 million over period as a whole

- EBITDA at just under EUR60 million

- Final quarter of 2018 gets off to a robust start, new outlook confirmed

Salzbergen, 15 November 2018. H&R GmbH & Co. KGaA (abbrev.: H&R KGaA; ISIN DE000A2E4T77) has confirmed its preliminary figures for the first nine months of 2018: Between January and September 2018, the company achieved an operating income (EBITDA - Consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment) of EUR 59.7 million (same period of the previous year: EUR 80.8 million). Net profit to shareholders was EUR 20.2 million, down on the previous year (nine months 2017): EUR 33.9 million). In total, H&R KGaA thus generated earnings per share of EUR 0.55. Due to raw material prices, sales of EUR 833.7 million exceeded again the prior-year figure (first nine months of 2017: EUR 784.9 million).

Overview of the main key figures:

in EUR Million First 9 months of 2018 First 9 months of 2017 Absolute diff.
Sales revenues 833.7 784.9 48.8
Operating income (EBITDA) 59.7 80.8 -21.1
EBIT 34.4 54.4 -20.0
EBT 28.6 47.6 -19.0
Net profit attributable to shareholders 20.2 33.9 -13.7
Consolidated earnings per share (EUR) 0.55 0.93 -0.38
Operating cash flow 9.3 44.7 -35.4
Free cash flow -34.7 6.9 -41.4
  Q3-2018 Q3-2017 Absolute diff.
Sales revenues 283.3 257.2 26.1
Operating income (EBITDA) 18.5 27.9 -9.4
EBIT 10.1 19.3 -9.2
EBT 7.7 17.2 -9.5
Net profit/loss to shareholders 5.3 12.5 -7.2
Consolidated earnings per share (EUR) 0.14 0.34 -0.20
Operating cash flow 24.9 39.7 -14.8
Free cash flow 5.8 24.3 -18.5
  9/30/2018 12/31/2017 Absolute diff.
Balance sheet total 744.7 662.6 82.1
Group equity 355.4 342.7 12.7
Equity Ratio (%) 47.7 51.7 -4.0*

* Indicated in percentage points.

All segments generated positive earnings contributions. With EBITDA of EUR 36.6 million (first nine months of 2017: EUR 53,4 Mio.) the ChemPharm Refining segment contributed the major share to earnings. However, the price increases for raw materials were also most noticeable in this segment. Sales in this segment nevertheless increased along with raw material prices to reach EUR522.6 million (first nine months of 2017: EUR 475.9 million). At EUR 23.2 million, the international activities bundled in the ChemPharm Sales segment recorded a lower but on the whole comparable operating income for the first nine months of this year (first nine months of 2017: EUR 26.9 million). From January to September 2018, revenues amounted to EUR 275.7 million (first nine months of 2017: EUR 271.1 million). The Plastics segment generated EBITDA of EUR 2.9 million in the first nine months of 2018 (first nine months of 2017: EUR 3.4 million). Sales, at EUR43 million, remained largely stable with respect to comparable figures from the previous year (first nine months of 2017: EUR 44.8 Mio.).

For the rest of the year, the main challenges - whether economic or global political - are likely to remain essentially unchanged. Nevertheless, the final quarter has begun somewhat more positively for the company as a whole. Accordingly, the Executive Board confirms the current earnings forecast of EUR 70.0 to EUR 75.0 million.

For further statements on the trends in business performance and earnings, the company refers to the quarterly report for the third quarter of 2018 published today, which is available for download at www.hur.com in the "Investor Relations" section.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Tel.: +49 40 43218-321, Fax: +49 40 43218-390
e-mail: ties.kaiser@hur.com ; www.hur.com

H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.

15.11.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Phone: +49 (0)40 43 218 321
Fax: +49 (0)40 43 218 390
E-mail: investor.relations@hur.com
Internet: www.hur.com
ISIN: DE000A2E4T77
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange

End of News DGAP News Service

745853  15.11.2018